Impact of European medicines agency regulatory action on hydroxyzine initiation, discontinuation and switching to other medicines in Scotland, England, Denmark and the Netherlands: An Interrupted time series regression analysis

Daniel R. Morales; Tom MacDonald; Rob Flynn; Steve Morant; Isla Mackenzie; Alex Doney; Lyn Mitchell; Jesper Hallas; Anton Pottergard; Martin Ernst; Lisa Smits; Ron Herings; Jetty Overbeek; Marion Bennie; Chris Robertson; Li Wei; Lizzie Nicholson; Tatiana Macfarlane

Impact of European medicines agency regulatory action on hydroxyzine initiation, discontinuation and switching to other medicines in Scotland, England, Denmark and the Netherlands: An Interrupted time series regression analysis

Daniel R. Morales, Tom MacDonald, Rob Flynn, Steve Morant, Isla Mackenzie, Alex Doney, Lyn Mitchell, Jesper Hallas, Anton Pottergard, Martin Ernst, Lisa Smits, Ron Herings, Jetty Overbeek, Marion Bennie, Chris Robertson, Li Wei, Lizzie Nicholson, Tatiana Macfarlane

Klinisk farmakologi, farmaci og Miljømedicin

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	4619
Tidsskrift	Pharmacoepidemiology and Drug Safety
Vol/bind	29
Udgave nummer	Suppl. 3
Sider (fra-til)	505
Antal sider	1
ISSN	1053-8569
Status	Udgivet - okt. 2020
Begivenhed	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management - Varighed: 16. sep. 2020 → 17. sep. 2020

Konference

Konference	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Periode	16/09/2020 → 17/09/2020

Dokumenter og links

https://doi.org/10.1002/pds.5114

Citationsformater

Morales, D. R., MacDonald, T., Flynn, R., Morant, S., Mackenzie, I., Doney, A., Mitchell, L., Hallas, J., Pottergard, A., Ernst, M., Smits, L., Herings, R., Overbeek, J., Bennie, M., Robertson, C., Wei, L., Nicholson, L., & Macfarlane, T. (2020). Impact of European medicines agency regulatory action on hydroxyzine initiation, discontinuation and switching to other medicines in Scotland, England, Denmark and the Netherlands: An Interrupted time series regression analysis. Pharmacoepidemiology and Drug Safety, 29(Suppl. 3), 505. [4619]. https://doi.org/10.1002/pds.5114

@article{88b8d54db7894f5d8bee5692256df74f,

title = "Impact of European medicines agency regulatory action on hydroxyzine initiation, discontinuation and switching to other medicines in Scotland, England, Denmark and the Netherlands: An Interrupted time series regression analysis",

author = "Morales, {Daniel R.} and Tom MacDonald and Rob Flynn and Steve Morant and Isla Mackenzie and Alex Doney and Lyn Mitchell and Jesper Hallas and Anton Pottergard and Martin Ernst and Lisa Smits and Ron Herings and Jetty Overbeek and Marion Bennie and Chris Robertson and Li Wei and Lizzie Nicholson and Tatiana Macfarlane",

year = "2020",

month = oct,

language = "English",

volume = "29",

pages = "505",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "Wiley",

number = "Suppl. 3",

note = "36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management ; Conference date: 16-09-2020 Through 17-09-2020",

}

Morales, DR, MacDonald, T, Flynn, R, Morant, S, Mackenzie, I, Doney, A, Mitchell, L, Hallas, J, Pottergard, A, Ernst, M, Smits, L, Herings, R, Overbeek, J, Bennie, M, Robertson, C, Wei, L, Nicholson, L & Macfarlane, T 2020, 'Impact of European medicines agency regulatory action on hydroxyzine initiation, discontinuation and switching to other medicines in Scotland, England, Denmark and the Netherlands: An Interrupted time series regression analysis', Pharmacoepidemiology and Drug Safety, bind 29, nr. Suppl. 3, 4619, s. 505. <https://doi.org/10.1002/pds.5114>

Impact of European medicines agency regulatory action on hydroxyzine initiation, discontinuation and switching to other medicines in Scotland, England, Denmark and the Netherlands: An Interrupted time series regression analysis. / Morales, Daniel R.; MacDonald, Tom; Flynn, Rob et al.

I: Pharmacoepidemiology and Drug Safety, Bind 29, Nr. Suppl. 3, 4619, 10.2020, s. 505.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Impact of European medicines agency regulatory action on hydroxyzine initiation, discontinuation and switching to other medicines in Scotland, England, Denmark and the Netherlands: An Interrupted time series regression analysis

AU - Morales, Daniel R.

AU - MacDonald, Tom

AU - Flynn, Rob

AU - Morant, Steve

AU - Mackenzie, Isla

AU - Doney, Alex

AU - Mitchell, Lyn

AU - Hallas, Jesper

AU - Pottergard, Anton

AU - Ernst, Martin

AU - Smits, Lisa

AU - Herings, Ron

AU - Overbeek, Jetty

AU - Bennie, Marion

AU - Robertson, Chris

AU - Wei, Li

AU - Nicholson, Lizzie

AU - Macfarlane, Tatiana

PY - 2020/10

Y1 - 2020/10

M3 - Conference abstract in journal

SN - 1053-8569

VL - 29

SP - 505

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - Suppl. 3

M1 - 4619

T2 - 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management

Y2 - 16 September 2020 through 17 September 2020

ER -

Morales DR, MacDonald T, Flynn R, Morant S, Mackenzie I, Doney A et al. Impact of European medicines agency regulatory action on hydroxyzine initiation, discontinuation and switching to other medicines in Scotland, England, Denmark and the Netherlands: An Interrupted time series regression analysis. Pharmacoepidemiology and Drug Safety. 2020 okt.;29(Suppl. 3):505. 4619.